Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents
Gadolinium(III) complexes are strong enhancers of magnetic resonance imaging (MRI) signals, thus are widely used as contrast agents despite their potential toxicity. Here, the authors review ligand design approaches aimed at improving the stability of Gd(III)-based MRI contrast agents.
Guardado en:
Autores principales: | Thomas J. Clough, Lijun Jiang, Ka-Leung Wong, Nicholas J. Long |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f20637c1e52446f1b3f9afd3a401fc33 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T1 relaxometry in patients with prostate cancer
por: Nikita Sushentsev, et al.
Publicado: (2020) -
Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement
por: Scott D Swanson, et al.
Publicado: (2008) -
PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
por: Charmainne Cruje, et al.
Publicado: (2021) -
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
por: Estelrich J, et al.
Publicado: (2015) -
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
por: Patil R, et al.
Publicado: (2020)